CS Paper Radar

A small HER2 reader for routine H&E slides: real-world deployment

Thang Tran, Lan Dang

cs.CV q-bio.QMcs.LGcs.SE ·submitted 2026-10-09 04:43 UTC · v1
benchmarkcode/data

Abstract

HER2 status decides who receives HER2-targeted therapy. Pathologists score HER2 protein by immunohistochemistry (IHC); equivocal IHC 2+ tumours, their hardest calls, wait for in situ hybridisation (ISH). We built a HER2 reader for routine H&E slides, owned end to end, as a baseline for pathologists. A 22M-parameter ViT-S/16 tile encoder was trained on public TCGA slides by self-supervision, distillation from H-optimus-0 and two rounds of JEPA refinement; five cross-validated attention-based slide classifiers average their probabilities; and an operating point is fixed on training data. Compared under one paired ten-seed protocol, readers on our encoder rank first of 7 on external validation from TCGA-BRCA to Yale-HER2 (AUC 0.812), level with readers on encoders 4 and 50 times larger. We also rebuilt PathBench's encoder benchmark on public cohorts; our replica reproduces its published order of reference encoders, and under it our encoder ranks first of 7 on TCGA-BRCA (0.689) and sits level with H-optimus-0 and Phikon on Yale-HER2 (0.897). On three external hospitals our deployed reader reaches AUC 0.82 on Yale-HER2 (about 0.81 with training slides balanced for tissue size), 0.75 on HEROHE and 0.63 on BCNB biopsies, and among HEROHE's 85 IHC 2+ cases it ranks ISH-amplified above non-amplified tumours at 0.76, best among our TCGA-trained readers. Per-laboratory score normalisation and a laboratory's own slides improve it further on a new site. Without a GPU our reader needs 5-6 s per slide. It serves as a research-use pre-read in a pathology platform, where it proposes a probability and a call beside IHC and helps prioritise ISH for equivocal cases. Weights, per-slide predictions and the data behind every figure are public at https://huggingface.co/cloudkites/her2-reader.

Comment
32 pages, 12 figures, 17 tables (including supplementary material). Research use only. Weights and data: https://huggingface.co/cloudkites/her2-reader

Closest papers

Nearest neighbours by meaning across the whole index.

DistillPath: An Efficient 22M Distilled Pathology Encoder Approaching Large Foundation Model Performance

cs.CV ·2026-08-18 ·Ramon Kaspar, Andrey Ignatov, Valentina Boeva
publishedcode/datahot direction similarity 0.63
Abstract · 26 pages, 5 figures. Accepted at the ECCV 2026 Workshop on Medical Foundation Models and Benchmarks (MedFM-Bench)

Many high-performing pathology tile encoders are now foundation models with hundreds of millions to over a billion parameters. Encoding and storing the thousands of tiles in each whole-slide image with such models is costly on commodity hardware, so compact encoders that retain useful downstream performance are a valuable alternative. We present DistillPath-KS16, which starts from the existing 22M kaiko ViT-S/16 encoder and improves it by distilling from released pathology encoders used as frozen teachers. The recipe reads only the teachers' final class and patch tokens and trains on 6,000 public slides, needing neither their DINO nor iBOT pretraining heads nor a billion-tile corpus, so it applies to any released encoder that exposes backbone tokens. We distill four teachers spanning 86M to 1.1B parameters into the same student. Every variant improves the kaiko baseline on all three benchmarks we use, EVA, HEST, and PLISM, and the strongest teacher is task-dependent. On the seven-task EVA mean, DistillPath-KS16-Virchow2 reaches $0.795$, within $0.015$ points of Virchow2, the top-scoring model in our evaluation, at about $29\times$ fewer parameters; it also scores above H0-mini and GPFM on this aggregate metric, though that advantage is task-concentrated rather than uniform. Because it remains a 22M ViT-S/16 with 384-dimensional features, DistillPath-KS16 runs more than $25\times$ faster than Virchow2. Code is available at https://github.com/RamonKaspar/DistillPath, and released model weights are available at https://huggingface.co/collections/RamonK/distillpath.

0.85

HERO: Histology Encoder for Robust Representation in Oncology

cs.CV ·2026-09-28 ·Zhi Li, Eghbal Amidi, Yating Cheng, Tyson Dawson, Gorkem Can Ates +9 more
benchmarkcode/data similarity 0.58
Abstract · 22 pages, 4 figures, 13 tables; author information updated; scientific content unchanged

Foundation models trained on large pathology image corpora now provide strong, transferable representations for computational pathology. Over the past few years a series of such models has been released, each trained on more slides than the last; on standard classification and segmentation benchmarks, the leading models are now separated by small margins. In clinical use, however, the foundation model is applied to images from hospitals, scanners, and staining protocols outside its training data. Encoders generally embed these acquisition factors alongside biological information, which may introduce downstream errors and hinder safe clinical adoption. A pathology foundation model should therefore be robust to acquisition shift without giving up representation quality, yet robustness is seldom the axis along which models are compared. In this report, we introduce HERO (Histology Encoder for Robust Representation in Oncology), a ViT-G/14 pathology foundation model trained with the DINO and iBOT objectives and refined with high-resolution Gram anchoring on a morphology-balanced corpus of 500 million tiles from approximately 575,000 clinical whole-slide images. Across the evaluated public benchmarks, HERO shows the strongest robustness to center, scanner, and stain variation among the compared state-of-the-art foundation models, performs comparably on tile-level classification, segmentation, and gene-expression prediction, ranks first on average across 39 evaluated slide-level clinical tasks, and, under an equal-weighted framework-level analysis, has the best average rank across the six benchmark frameworks.

0.22

HEmIF-Bench: Benchmarking H&E-to-mIF Models BeyondVirtual-StainFidelity

cs.CV ·2026-11-15 ·Fuxian Zhao, Hyokeun Park
benchmark similarity 0.58
Abstract · 11 pages, 3 figures, 2 tables

Hematoxylin and eosin (H&E)-to-multiplex immunofluorescence (mIF) generators predict spatial protein expression from routine histology, yet pixel-level marker reconstruction does not establish downstream utility. We present HEmIF-Bench, evaluating five frozen generators across eight datasets spanning molecular, cellular, tissue, and patient scales. HEmIF-Bench decouples internal encoder features from generated outputs, benchmarking both against the pathology foundation reference UNI2. Mirroring the clinical workflow where pathologists rely on mIF to define cell phenotypes, delineate tertiary lymphoid structures (TLSs) and germinal centers (GCs), and stratify patient risk, we evaluate external CD3 recovery, single-cell classification, dense nuclear segmentation, TLS/GC segmentation, and patient survival prediction. Across the benchmark, foundation-model-based MIPHEI-ViT leads among the generators, while non-foundation models show task-specific strengths. Comparing the two routes reveals that internal encoder features generally outperform generated outputs, and larger output marker panels do not guarantee stronger downstream utility across datasets. Moreover, neither internal encoder features nor generated outputs consistently surpass frozen UNI2. These findings show that pixel-level stain fidelity does not equate to downstream utility, and that generators trained at current paired-data scales have yet to surpass large-scale pure-H&E foundation models. With the expansion of paired translation cohorts and the advancement of foundation-based generative architectures, HEmIF-Bench establishes a definitive benchmark for tracking when H&E-to-mIF generation crosses the threshold to deliver genuine value beyond routine histology for tumor microenvironment analysis and precision oncology.

0.13

CRS-Bench: A Reference-Relative Reliability Benchmark for Medical Image Encoders

eess.IV cs.AIcs.CV ·2026-08-22 ·Xingtao Lin, Hangqi Ren, Caiwan Sun, You Chen
benchmark similarity 0.55
Abstract · 10 pages, 7 figures. Submitted to WACV 2027

Pretrained image encoders are central to medical image classification, where expert annotation is costly and task-specific cohorts are often limited. As the model space expands from general-purpose to broad-medical and specialty-specific encoders, selecting the representation becomes a substantive modeling decision. Clean-test discrimination alone is insufficient for this purpose: encoders with similar AUROC can differ in calibration, label efficiency, and stability under acquisition perturbations or distribution shift. We introduce CRS-Bench, a controlled benchmark for multi-objective medical encoder selection. CRS-Bench evaluates 15 pretrained encoder families across dermatology, ophthalmology, and radiology using ISIC 2019, APTOS 2019, and CheXpert, with CheXpert-to-MIMIC-CXR as an observed institutional shift, yielding 17,575 controlled run records and 3,515 seed-aggregated metric rows. Each encoder is characterized along four operational reliability dimensions: discrimination, calibration, label efficiency, and robustness. We summarize these dimensions using the Clinical Reliability Score (CRS), a Pareto-aware, reference-relative score combining dominance, profile balance, and worst-axis performance. AUROC and CRS are positively associated but not decision-equivalent: 21 of 105 pairwise orderings reverse, with a mean absolute rank displacement of 1.87. Paired-seed bootstrap analysis identifies PanDerm, MedSigLIP, and MedGemma as a stable leading reliability tier rather than a statistically resolved single leader. CRS-Bench provides a controlled framework for selecting medical image encoders from multi-axis reliability profiles rather than clean-test AUROC alone.

0.33

Can You Trust Frozen Hematology Foundation Models under Acquisition Shift?

cs.CV cs.AIq-bio.QM ·2026-08-25 ·Jai Kumar Sharma, Peeyush Tapadiya
publishedbenchmarkcode/data similarity 0.55
Abstract · Accepted at the HemaRAI 2026 workshop (MICCAI 2026 satellite event), oral presentation; to appear in MICCAI 2026 Satellite Events, LNCS, Spr…

Frozen hematology foundation-model (FM) embeddings reach near-saturated in-domain white-blood-cell (WBC) accuracy, but clinical deployment demands reliability across scanners, sites, stains and preparation pipelines. We audit 15 frozen encoders (hematology, pathology, and general vision) across four public single-cell acquisition domains along two axes: accuracy robustness and calibration. In-domain linear-probe macro-F1 is saturated (0.98-0.997), yet cross-dataset macro-F1 drops 34-72% and rankings re-order: DinoBloom-L, the in-domain best, falls to 10th of 15 on the most-shifted target (MLL23) at the benchmark's shared 224-px input, behind RedDino and several general and pathology encoders. Rank transfer is probe-dependent: 1-NN retrieval is more stable on average than a source-fitted linear head (median $ρ$ 0.65 vs 0.45), but neither probe universally predicts target robustness. Calibration also collapses: source-trained probes are nearly calibrated in-domain (expected calibration error, ECE, 0.004) but confidently wrong off-domain (ECE 0.35), and source-fitted temperature scaling transfers poorly. We further audit pretraining exposure and identify MLL23 as DinoBloom's internal cohort; because DinoBloom's only held-out dataset is also our source domain, this benchmark cannot isolate exposure from scanner-associated shift. Label-free adaptation and marginal-entropy-based model selection appear safe under balanced evaluation but fail under realistic WBC class-prior shift. Class-Balanced Re-standardization (CBR), a training-free pseudo-label-balanced feature normalization, improves all evaluated target-prior scenario means and partially improves calibration, although encoder-level exceptions and residual miscalibration remain. Hematology FM benchmarks must therefore jointly audit accuracy, calibration, exposure, and class-prior robustness.

0.43

What Language Adds, and at What Cost: Four Controlled Probes of Pathology Vision-Language Models

cs.CV q-bio.QM ·2026-10-19 ·Wenhao Zhang, Zhongliang Zhou, Yi Ping, Zirui Wang, Sheng Li
similarity 0.55
Abstract

Vision--language models (VLMs) promise to make computational pathology queryable and able to draft reports, but how much language adds beyond the vision backbone is unclear, because almost every system is evaluated by its developers on test sets of their own choosing. We grade published evidence by how it was produced and test four claims with controlled probes that reuse released checkpoints and public data, varying one input at a time. Report text adds prognostic signal: adding a frozen embedding of the stage-redacted report to a slide embedding raises the pooled C-index by 0.019 for progression-free interval and by 0.016 for overall survival across 1{,}633 TCGA patients, and restoring the stage statement adds nothing. Prompts add no measurable accuracy at inference: with features and pooling fixed, zero-shot classification is statistically indistinguishable from a supervised linear probe for lung and renal cancer subtyping. Slide-level question answering is barely grounded: SlideChat answers 74.82\% of SlideBench-VQA(TCGA) items correctly with the slide and 74.41\% without it, whereas its language backbone alone reaches 43.52\%. Paraphrasing leaves accuracy unchanged but flips 8--23\% of answers. Self-reported gains from agentic navigation and few-shot language priors cannot yet be attributed to language. Language thus adds real but narrow value, and we propose minimum controls that would expose these failure modes in future evaluations.

0.18

Reliability-Aware Benchmarking of Self-Supervised Learning in Histopathology Under 1-10% Label Regimes

cs.CV cs.LG ·2026-11-04 ·Alicem Koyun, Pranjali Changadeo Pingale, Sachin Mote, Gianluca Pizzuti
publishedbenchmarkcode/data similarity 0.55
Abstract · Oral presentation, CIBB 2026 (21st International Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics, Rome…

Expert annotation in digital pathology is expensive, and low-label regimes remain common in realistic histopathology workflows. Self-supervised learning (SSL) offers a practical way to learn transferable representations from unlabeled pathology images, but performance-only evaluation can hide unreliable confidence behavior under domain shift. We present a reliability-aware benchmark of SimCLR, BYOL, and an MAE-inspired masked-reconstruction baseline on PatchCamelyon (PCam; 96x96) and PANDA (prostate cancer) under 1%, 5%, and 10% labeled regimes with frozen-encoder linear probing. To address common single-run concerns, ResNet-18 results are repeated over 3 splits x 3 seeds (n=9) and ViT-B/16 over 1 split x 3 seeds (n=3) under practical compute constraints, with mean+/-std reporting and per-run logs. Beyond AUROC, accuracy, and F1-score, we report Expected Calibration Error and Brier score, OOD confidence diagnostics for cross-dataset PCam<->PANDA scoring, federated-vs-centralized SimCLR comparisons on PCam, and cross-dataset transfer to colorectal histology tiles. SSL improves label efficiency on the more controlled PCam task, while PANDA's noisier patch-level proxy can remain near coin-flip with higher variance. The study highlights that histopathology SSL should be assessed not only by ranking performance but also by calibration, robustness, and transparent reproducibility diagnostics before clinical interpretation.

0.46

Different Models, Shared Failures: Auditing Frozen-Encoder Pools for Medical Segmentation

cs.CV cs.AI ·2026-10-30 ·Eunseob Choi, Kyeonghun Kim, Hyuk-Jae Lee, Nam-Joon Kim
top venuecode/datahot direction similarity 0.55
Abstract · Accepted at NeurIPS 2026, Track on Evaluations and Datasets. 47 pages, 8 figures. Code and data: https://github.com/eunseobchoi/CoFailMed

Average segmentation accuracy and model count do not reveal whether models fail on the same cases. We present CoFailMed, an audit of correlated failures in pretrained-encoder pools for medical segmentation. Across five 2D tasks, we evaluate 11 public pretrained encoders (a controlled sample, not a census) using frozen features and separately trained $1\times 1$ readouts with four seeds per encoder. Shared-checkpoint pairs have the highest mean per-case Dice correlation. An expanded 17-encoder analysis shows that distinct checkpoints within the same encoder family remain more correlated than cross-family pairs. At the pooled 33rd-percentile Dice threshold, four-member pools drawn from distinct encoders have mean effective sizes of 1.56-2.92, estimated from failure correlations in pools with enough failures and passes per member. In the primary pool, richer readouts and fine-tuning narrow the Dice-correlation gap between pairs sharing a checkpoint (or the DINOv2-B/S release) and all other pairs. Yet dependence between different encoders can increase, and fine-tuning does not consistently increase effective pool size at 33rd-percentile thresholds recomputed for each training recipe. A smaller between-group gap can coexist with greater dependence. Pool evaluation should therefore report absolute dependence and threshold-specific effective size alongside accuracy and nominal pool size. The CoFailMed release provides aligned per-case traces, analysis scripts and study code to reproduce the central audit results.

0.63